Despite heterogeneity among APS patients, our data show that mere presence of circulating aPL induces multiple inflammatory pathways, particularly in individuals with ‘high-risk’ phenotype, a signature shared by all APS subtypes and consistent with the “first hit” of APS. The gene discussed is FASLG; the disease is autoimmune polyendocrinopathy.